Evolution Wealth Management’s Thermo Fisher Scientific TMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$57.7K Buy
115
+16
+16% +$7.68K 0.03% 288
2026
Q1
$48.7K Buy
99
+63
+175% +$34.2K 0.04% 281
2025
Q4
$20.9K Buy
36
+10
+38% +$5.66K 0.02% 351
2025
Q3
$12.6K Sell
26
-16
-38% -$7.45K 0.01% 342
2025
Q2
$17.1K Buy
+42
New +$17.6K 0.02% 304

Other funds holding TMO

Evolution Wealth Management's TMO Position: Q2 2026 in Review

Evolution Wealth Management increased its Thermo Fisher Scientific (TMO) stake by 16% in Q2 2026, buying an estimated $7.68K and bringing the position to 115 shares worth $57.7K. The position accounts for 0.03% of the portfolio, ranked #288.

Evolution Wealth Management first reported a position in TMO in Q2 2025 and has held it in 5 quarters since. 2,620 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

  • Evolution Wealth Management held 115 shares of Thermo Fisher Scientific worth $57.7K as of Q2 2026.
  • Evolution Wealth Management bought 16 Thermo Fisher Scientific shares in Q2 2026, an estimated $7.68K.
  • Thermo Fisher Scientific made up 0.03% of Evolution Wealth Management's portfolio in Q2 2026, its #288 holding.
  • Evolution Wealth Management first reported a position in Thermo Fisher Scientific in Q2 2025 and has held it in 5 quarters since.
  • 2,620 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on Evolution Wealth Management's 13F filing for Q2 2026, filed 21 Jul 2026.